Remdesivir is currently the world’s best hope for treating COVID-19. But it’s not a silver bullet.

The final in the three-part drama about the Chris Tarrant-fronted quiz show scandal is concerned with the dramatic court case

TV host said she was grateful for NHS workers doing 'so much' to help husband Derek Draper

The actress and her husband, Tom Hanks, were both hospitalised with the deadly virus

Two leading medicine experts share their knowledge of the virus

From calming clay masks to worthy blackhead treatments – these products actually work, according to consultant dermatologist Anjali Mahto

Receive a test and treatment in the same day

The 60-year-old actor has children Jack, 24, and Mercedes, 28, from his marriage to ex-wife Joanne Whalley and when Val

Tottenham legend Jimmy Greaves remains in hospital, "receiving the best possible treatment", as he battles an unspecified illness.

Former Liverpool defender Dominic Matteo has been given the all clear following treatment on a brain tumour.

HAIR loss treatment: The quest for magic cure to help halt the process of hair loss produces numerous searches and theories. Taking this essential mineral helps strengthen hair follicles which stimulate hair growth.

Chayse Gannon and his mother, forced to leave dad and baby brother behind, have changed accommodation around Sydney more than 12 times since he was diagnosed in February.

The nasal swab diagnostic test is far from infallible

California employers may dislike the new law on independent contractors, but they're devising a host of strategies to comply.

Trials to treat COVID-19 using the blood plasma from those who have already recovered from the illness have begun.

Tel Aviv University (TAU) researchers have developed a safe and accurate 3D imaging method to identify sperm cells moving at a high speed. The new method has the potential to significantly improve IVF treatments.

The first study to report use of the rheumatoid arthritis drug anakinra to treat COVID-19 patients found that high-dose anakinra was safe and was associated with respiratory improvements and reduced signs of cytokine storm [1] in 72% (21/29) of patients, according to results from patients studied for 21 days (enrolled from 17 to 27 March 2020) in a Milan hospital, published in The Lancet Rheumatology journal.

Reflecting research-driven changes in clinical practice, a revised set of evidence-based recommendations for the medical and surgical treatment of left-sided colonic diverticulitis has been published in Diseases of the Colon & Rectum (DC&R), the official journal of the American Society of Colon and Rectal Surgeons (ASCRS). The journal is published by Wolters Kluwer.

Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.

A two-week course of antiviral therapy with interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within 7 days of showing COVID-19 symptoms, is safe and more effective at reducing the duration of viral shedding than lopinavir-ritonavir alone in patients with mild to moderate illness, according to the first randomized trial of this triple combination therapy involving 127 adults (aged 18 and older) from six public hospitals in Hong Kong.

Hospitals in London and Birmingham have been supplied with fourteen units of convalescent plasma to see if it helps people who are battling

Researchers did not track side effects, but noted a hint that hydroxychloroquine might have damaged other organs, too.

Treat puzzles to help your cat claw their way out of boredom

These are the coronavirus stories you need to know about today.
Medscape Medical News

The Australian share market ends higher, despite Wall Street giving up most of its gains after leaked test results of a potential COVID-19 treatment prove disappointing.

As a medical oncologist in Connecticut, Dr. Justin Persico was all too aware of the people he treats, who would be at greater risk for exposure to the virus.

The World Health Organization joined with global leaders to accelerate production of vaccines and treatments aimed at stamping out the coronavirus.

The Philippines is promising better pay for its nurses to lure them to the front lines against COVID-19, but a legacy of exploitation and poor working conditions in the nation's hospitals has dampened the enthusiasm to answer the call.

The search for existing drugs that may help treat coronavirus infections now has researchers testing the heartburn drug Pepcid, among others.

Risk guides much of our medical care system. COVID-19 is showing us, unless we have developed immunity, we are all at risk.

Researchers at the National University of Singapore have developed a soft sensor and actuator to monitor bladder volume and help empty it on-demand. The device is intended to be implanted on the bladder surface during a surgical procedure to treat patients who cannot completely empty their bladders voluntarily. Patients can suffer from an underactive bladder […]

ZOLL Medical, a part of the Asahi Kasei Group, won EU clearance for its SuperSaturated Oxygen (SSO2) Therapy System to be used to minimize the damage that heart attacks cause within heart muscle. Approved about a year ago in the United States, SSO2 is the only option beyond percutaneous coronary intervention (stenting) that can help […]

Braeburn Pharmaceuticals' CAM2038 gets positive FDA review

NHS England has expanded access to targeted hormone therapies for advanced prostate cancer

This morning, Alydia Health, a tiny Menlo Park, Calif., startup co-founded by a 21-year-old woman, announced that it has secured $10 million in funding to test a medical device to prevent mothers from bleeding to death after childbirth.

Two different groups of researchers have shown that electrical stimulation of the spinal cord, combined with months of intense training, can allow some people who have been paralyzed to regain some walking ability.

Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) financial commitment and to supply products in support of the research / Plans to include more than 60 contributing research locations involving 6.000 patients

Pharmaceutical giants will bury treatments in a thicket of patents, making them unaffordable to the world’s poorest

• Coronavirus – latest updates
• See all our coronavirus coverage

How will the Covid-19 pandemic end? According to conventional wisdom, the crisis may ease in a few months, when some of the antiviral medicines on trial succeed. In a few years’ time, when a vaccine becomes available, we may eradicate the virus altogether.

Yet it’s unlikely that this is how the pandemic will actually play out. Although there is every indication that treatments for coronavirus may soon emerge, the mere fact of their existence is no guarantee that people will be able to access them. In fact, Covid-19 is more likely to end in the same way that every pandemic ends: treatments and vaccines will be buried in a thicket of patents – and pharmaceutical companies will ultimately make the decisions about who lives and who dies.

Related: The race to find a coronavirus treatment has one major obstacle: big pharma | Ara Darzi

Investors shrug off US growth gloom after promising data from remdesivir drug trial

• Coronavirus – latest updates
• See all our coronavirus coverage

Shares have soared on the world’s stock markets after investors shrugged off a deep slump in the US economy and pinned their hopes on a possible breakthrough in treatment for Covid-19.

Despite news that the longest expansion in US history came to an abrupt end in the first three months of 2020, financial markets were buoyed by an update from the American biopharma company Gilead Sciences on its experimental drug remdesivir.